Lightlake Therapeutics Inc. - Product Pipeline Review - 2014

Published: Jan, 2014 | Pages: 26 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Summary

Global Market Direct's pharmaceuticals report, "Lightlake Therapeutics Inc. - Product Pipeline Review - 2014" provides data on the Lightlake Therapeutics Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Lightlake Therapeutics Inc.'s corporate website, SEC filings, investor presentations and featured press releases, both from Lightlake Therapeutics Inc. and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

- Lightlake Therapeutics Inc. - Brief Lightlake Therapeutics Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Lightlake Therapeutics Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Lightlake Therapeutics Inc. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Lightlake Therapeutics Inc.'s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Lightlake Therapeutics Inc.'s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Lightlake Therapeutics Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Lightlake Therapeutics Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Lightlake Therapeutics Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Lightlake Therapeutics Inc. and identify potential opportunities in those areas.

 Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Lightlake Therapeutics Inc. Snapshot 4
Lightlake Therapeutics Inc. Overview 4
Key Information 4
Key Facts 4
Lightlake Therapeutics Inc. - Research and Development Overview 5
Key Therapeutic Areas 5
Lightlake Therapeutics Inc. - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
Lightlake Therapeutics Inc. - Pipeline Products Glance 9
Lightlake Therapeutics Inc. - Clinical Stage Pipeline Products 9
Phase II Products/Combination Treatment Modalities 9
Phase I Products/Combination Treatment Modalities 10
Lightlake Therapeutics Inc. - Drug Profiles 11
LT-12 11
Product Description 11
Mechanism of Action 11
R&D Progress 11
LT-20 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
LT-21 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
LT-22 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
Lightlake Therapeutics Inc. - Pipeline Analysis 16
Lightlake Therapeutics Inc. - Pipeline Products by Therapeutic Class 16
Lightlake Therapeutics Inc. - Pipeline Products by Target 17
Lightlake Therapeutics Inc. - Pipeline Products by Route of Administration 18
Lightlake Therapeutics Inc. - Pipeline Products by Molecule Type 19
Lightlake Therapeutics Inc. - Pipeline Products by Mechanism of Action 20
Lightlake Therapeutics Inc. - Recent Pipeline Updates 21
Lightlake Therapeutics Inc. - Company Statement 23
Lightlake Therapeutics Inc. - Locations And Subsidiaries 24
Head Office 24
Appendix 25
Methodology 25
Coverage 25
Secondary Research 25
Primary Research 25
Expert Panel Validation 25
Contact Us 26
Disclaimer 26

List of Tables
Lightlake Therapeutics Inc., Key Information 4
Lightlake Therapeutics Inc., Key Facts 4
Lightlake Therapeutics Inc. - Pipeline by Indication, 2014 6
Lightlake Therapeutics Inc. - Pipeline by Stage of Development, 2014 7
Lightlake Therapeutics Inc. - Monotherapy Products in Pipeline, 2014 8
Lightlake Therapeutics Inc. - Phase II, 2014 9
Lightlake Therapeutics Inc. - Phase I, 2014 10
Lightlake Therapeutics Inc. - Pipeline by Therapeutic Class, 2014 16
Lightlake Therapeutics Inc. - Pipeline by Target, 2014 17
Lightlake Therapeutics Inc. - Pipeline by Route of Administration, 2014 18
Lightlake Therapeutics Inc. - Pipeline by Molecule Type, 2014 19
Lightlake Therapeutics Inc. - Pipeline Products by Mechanism of Action, 2014 20
Lightlake Therapeutics Inc. - Recent Pipeline Updates, 2014 21